Bevacizumab: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 July 2010

  • curprev 14:5314:53, 17 July 2010‎ imported>Howard C. Berkowitz‎ 2,879 bytes +2,879‎ No edit summary
  • curprev 14:4914:49, 17 July 2010‎ imported>Howard C. Berkowitz‎ 2,689 bytes +602‎ No edit summary
  • curprev 12:5412:54, 17 July 2010‎ imported>Howard C. Berkowitz‎ m 2,087 bytes +2,087‎ No edit summary
  • curprev 12:2612:26, 17 July 2010‎ imported>Howard C. Berkowitz‎ 2,102 bytes +2,102‎ No edit summary
  • curprev 12:2312:23, 17 July 2010‎ imported>Howard C. Berkowitz‎ 2,000 bytes +13‎ No edit summary
  • curprev 12:2212:22, 17 July 2010‎ imported>Howard C. Berkowitz‎ 1,987 bytes +1,987‎ New page: '''Bevacizumab''' is an "anti-VEGF ([http://www.ncbi.nlm.nih.gov/sites/entrez?db=protein&term=NP_001020537 Entrez protein]) monoclonal antibody consisting of humanized murine antibody with...
Retrieved from "https://citizendium.org/wiki/Bevacizumab"